Influenza and COVID-19: What does co-existence mean?
Influenza and COVID-19: What does co-existence mean?
复制标题
DOI：
10.1111/irv.12824
复制
发表时间：
2021-05
影响因子：
4.4
通讯作者：
Tam JS
中科院分区：
文献类型：
--
作者：
Chotpitayasunondh T;Fischer TK;Heraud JM;Hurt AC;Monto AS;Osterhaus A;Shu Y;Tam JS
由新型冠状病毒SARS-CoV-2引起的COVID-19大流行继续对全球的医疗保健和社会系统产生重大影响。由于COVID-19的临床和流行病学特征与流感有许多相似之处，因此确保对这两种呼吸道疾病进行最佳管理非常重要，因为我们预计它们会继续共同循环。特别是，需要确保具备有效的监测和诊断能力，以监测这些和其他呼吸道病毒，因为这将为有关疾病的适当临床管理决定提供依据。因此，我们向持份者、公共卫生当局、初级保健医生和监测机构提出一系列关键建议，以帮助减轻流感疫情和COVID-19大流行并发的综合风险。我们提倡谨慎使用流感疫苗和抗病毒药物，特别是在并发症高危人群中，医护人员也被视为接种疫苗的优先事项。越来越多地使用远程医疗和接触者追踪等新兴技术可能会永久改变我们管理传染病的方法。使用这些技术，以及现有的制药策略，将确保我们实现应对流感和COVID-19综合威胁所需的全球公共卫生措施的整体方法。确保这种方法是最佳的将是关键，因为我们从反应性大流行应对转向准备长期管理与这些呼吸道病原体相关的显著临床负担。
The COVID‐19 pandemic caused by the novel coronavirus SARS‐CoV‐2 continues to have a major impact on healthcare and social systems throughout the world. As the clinical and epidemiological features of COVID‐19 have many parallels with influenza, it is important to ensure optimal management of both respiratory diseases as we anticipate their continued co‐circulation. In particular, there is a need to ensure that effective surveillance and diagnostic capacities are in place to monitor these and other respiratory viruses, as this will underpin decisions on the appropriate clinical management of the respective diseases. As such, we propose a series of key recommendations for stakeholders, public health authorities, primary care physicians and surveillance bodies that will help mitigate the combined risks of concurrent influenza epidemics and the COVID‐19 pandemic. We advocate the judicious use of influenza vaccines and antivirals, particularly among groups at high risk of complications, with healthcare workers also considered a priority for vaccination. It is likely that the increased use of emerging technologies such as telemedicine and contact tracing will permanently change our approach to managing infectious disease. The use of these technologies, alongside existing pharmaceutical strategies, will ensure that we achieve a holistic approach to the global public health measures needed to deal with the combined threat of influenza and COVID‐19. Ensuring that this approach is optimal will be key as we move from a reactive pandemic response towards preparing for the long‐term management of the remarkable clinical burden associated with these respiratory pathogens.
登录
查看更多内容
影响因子：
28.2
作者：
Gutierrez-Pizarraya, A.;Perez-Romero, P.;Cordero, E.
通讯作者：
Cordero, E.
影响因子：
12.7
作者：
Ding, Qiang;Lu, Panpan;Liu, Mei
通讯作者：
Liu, Mei
影响因子：
56.3
作者：
Ison, Michael G.;Portsmouth, Simon;Hayden, Frederick G.
通讯作者：
Hayden, Frederick G.
影响因子：
76.2
作者：
Feng, Shuo;Chiu, Susan S.;Cowling, Benjamin J.
通讯作者：
Cowling, Benjamin J.
季节性，大流行和人畜共患流感的繁殖数量的估计值：对文献的系统评价。
影响因子：
3.7
作者：
Biggerstaff M;Cauchemez S;Reed C;Gambhir M;Finelli L
通讯作者：
Finelli L